Senior insider sale
CBO & EVP at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$1.31M
39.88K shares
What this filing means
KASSBERG THOMAS RICHARD plans to sell 39.88K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $1.31M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/23/2023ACC: 0001950047-23-004591
Officer· CBO & EVP
Since Mar 2019
39.88K
Shares to sell
$1.31M
Approx. market value
39.88K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/23/2023
39.88KTotal acquired39.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/23/2023 | Stock Option Exercise Cash | 39.88K | — |
| Total | 39.88K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
39.88K
Market value
$1.31M
10/23/2023
Total
Units
39.88K
Value
$1.31M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/23/2023 | 39.88K | $1.31M | NASDAQ | Planned |
| Total | 39.88K | $1.31M | ||